The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Valsartan-Hydrochlorothiazide Market Research Report 2025

Global Valsartan-Hydrochlorothiazide Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1804403

No of Pages : 98

Ask Your Query

Synopsis

This drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: valsartan and hydrochlorothiazide. Valsartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a "water pill" (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water.

The global Valsartan-Hydrochlorothiazide market was valued at US$ 541 million in 2023 and is anticipated to reach US$ 800.5 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.

North American market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Valsartan-Hydrochlorothiazide include Novartis, Teva, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Par Pharmaceutical, Huaren Pharmaceutical, Mylan and Alembic Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Valsartan-Hydrochlorothiazide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan-Hydrochlorothiazide.

Report Scope

The Valsartan-Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan-Hydrochlorothiazide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Valsartan-Hydrochlorothiazide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Novartis
  • Teva
  • Lupin
  • Aurobindo Pharma
  • Torrent Pharmaceuticals
  • Par Pharmaceutical
  • Huaren Pharmaceutical
  • Mylan
  • Alembic Pharmaceuticals
  • Zhejiang Huahai Pharmaceutical
  • APOTEX
  • MACLEODS
  • Chongqing Conquer Pharmaceutical
  • Beijing Second Pharmaceutical
  • Cisen Pharmaceutical

Segment by Type

  • Tablet
  • Capsule

Segment by Application

  • Hospital
  • Drug Store

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan-Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Valsartan-Hydrochlorothiazide Market Overview
1.1 Product Overview and Scope of Valsartan-Hydrochlorothiazide
1.2 Valsartan-Hydrochlorothiazide Segment by Type
1.2.1 Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.3 Valsartan-Hydrochlorothiazide Segment by Application
1.3.1 Global Valsartan-Hydrochlorothiazide Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Valsartan-Hydrochlorothiazide Market Size Estimates and Forecasts
1.4.1 Global Valsartan-Hydrochlorothiazide Revenue 2019-2030
1.4.2 Global Valsartan-Hydrochlorothiazide Sales 2019-2030
1.4.3 Global Valsartan-Hydrochlorothiazide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valsartan-Hydrochlorothiazide Market Competition by Manufacturers
2.1 Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valsartan-Hydrochlorothiazide Average Price by Manufacturers (2019-2024)
2.4 Global Valsartan-Hydrochlorothiazide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
2.7 Valsartan-Hydrochlorothiazide Market Competitive Situation and Trends
2.7.1 Valsartan-Hydrochlorothiazide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valsartan-Hydrochlorothiazide Players Market Share by Revenue
2.7.3 Global Valsartan-Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valsartan-Hydrochlorothiazide Retrospective Market Scenario by Region
3.1 Global Valsartan-Hydrochlorothiazide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valsartan-Hydrochlorothiazide Global Valsartan-Hydrochlorothiazide Sales by Region: 2019-2030
3.2.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2019-2024
3.2.2 Global Valsartan-Hydrochlorothiazide Sales by Region: 2025-2030
3.3 Global Valsartan-Hydrochlorothiazide Global Valsartan-Hydrochlorothiazide Revenue by Region: 2019-2030
3.3.1 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2019-2024
3.3.2 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2025-2030
3.4 North America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.4.1 North America Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.4.3 North America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.5.1 Europe Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.5.3 Europe Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.6.1 Asia Pacific Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.6.3 Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.7.1 Latin America Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.7.3 Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2019-2030)
4.1.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2019-2024)
4.1.2 Global Valsartan-Hydrochlorothiazide Sales by Type (2025-2030)
4.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2019-2030)
4.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2019-2030)
4.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Type (2019-2024)
4.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2025-2030)
4.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2019-2030)
4.3 Global Valsartan-Hydrochlorothiazide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2019-2030)
5.1.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2019-2024)
5.1.2 Global Valsartan-Hydrochlorothiazide Sales by Application (2025-2030)
5.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2019-2030)
5.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2019-2030)
5.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Application (2019-2024)
5.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2025-2030)
5.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2019-2030)
5.3 Global Valsartan-Hydrochlorothiazide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Corporation Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Torrent Pharmaceuticals
6.5.1 Torrent Pharmaceuticals Corporation Information
6.5.2 Torrent Pharmaceuticals Description and Business Overview
6.5.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.5.5 Torrent Pharmaceuticals Recent Developments/Updates
6.6 Par Pharmaceutical
6.6.1 Par Pharmaceutical Corporation Information
6.6.2 Par Pharmaceutical Description and Business Overview
6.6.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.6.5 Par Pharmaceutical Recent Developments/Updates
6.7 Huaren Pharmaceutical
6.6.1 Huaren Pharmaceutical Corporation Information
6.6.2 Huaren Pharmaceutical Description and Business Overview
6.6.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.7.5 Huaren Pharmaceutical Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Alembic Pharmaceuticals
6.9.1 Alembic Pharmaceuticals Corporation Information
6.9.2 Alembic Pharmaceuticals Description and Business Overview
6.9.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.9.5 Alembic Pharmaceuticals Recent Developments/Updates
6.10 Zhejiang Huahai Pharmaceutical
6.10.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.10.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.10.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.11 APOTEX
6.11.1 APOTEX Corporation Information
6.11.2 APOTEX Valsartan-Hydrochlorothiazide Description and Business Overview
6.11.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
6.11.5 APOTEX Recent Developments/Updates
6.12 MACLEODS
6.12.1 MACLEODS Corporation Information
6.12.2 MACLEODS Valsartan-Hydrochlorothiazide Description and Business Overview
6.12.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
6.12.5 MACLEODS Recent Developments/Updates
6.13 Chongqing Conquer Pharmaceutical
6.13.1 Chongqing Conquer Pharmaceutical Corporation Information
6.13.2 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.13.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.13.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
6.14 Beijing Second Pharmaceutical
6.14.1 Beijing Second Pharmaceutical Corporation Information
6.14.2 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.14.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.14.5 Beijing Second Pharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Corporation Information
6.15.2 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.15.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan-Hydrochlorothiazide Industry Chain Analysis
7.2 Valsartan-Hydrochlorothiazide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan-Hydrochlorothiazide Production Mode & Process
7.4 Valsartan-Hydrochlorothiazide Sales and Marketing
7.4.1 Valsartan-Hydrochlorothiazide Sales Channels
7.4.2 Valsartan-Hydrochlorothiazide Distributors
7.5 Valsartan-Hydrochlorothiazide Customers
8 Valsartan-Hydrochlorothiazide Market Dynamics
8.1 Valsartan-Hydrochlorothiazide Industry Trends
8.2 Valsartan-Hydrochlorothiazide Market Drivers
8.3 Valsartan-Hydrochlorothiazide Market Challenges
8.4 Valsartan-Hydrochlorothiazide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock